Back to KROS
BlackRock Finance, Inc. → KROS
BlackRock Finance, Inc. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$542K
Q2 2024
Peak value
$58M
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $732K |
| Q2 2024 | $3K |
| Q2 2024 | $372K |
| Q2 2024 | $3.3M |
| Q2 2024 | $7.2M |
| Q2 2024 | $58M |
| Q2 2024 | $40.3M |
| Q2 2024 | $11K |
| Q2 2024 | $243K |
| Q2 2024 | $569K |
| Q2 2024 | $3.3M |
| Q2 2024 | $46K |
| Q2 2024 | $14K |
| Q2 2024 | $221K |
| Q2 2024 | $542K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2024 | $542K | 11.9K | — | — |
| Q2 2024 | $221K | 4.8K | — | — |
| Q2 2024 | $14K | 297 | — | — |
| Q2 2024 | $46K | 996 | — | — |
| Q2 2024 | $3.3M | 71.6K | — | — |
| Q2 2024 | $569K | 12.4K | — | — |
| Q2 2024 | $243K | 5.3K | — | — |
| Q2 2024 | $11K | 232 | — | — |
| Q2 2024 | $40.3M | 882.4K | — | — |
| Q2 2024 | $58M | 1.27M | — | — |
| Q2 2024 | $7.2M | 157.6K | — | — |
| Q2 2024 | $3.3M | 73.0K | — | — |
| Q2 2024 | $372K | 8.1K | — | — |
| Q2 2024 | $3K | 57 | — | — |
| Q2 2024 | $732K | 16.0K | — | — |